Scienture Holdings Inc
SCNX1.940USD
+0.030+1.57%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
24.28MMarket Cap
LossP/E TTM
More Details of Scienture Holdings Inc Company
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Company Info
Ticker SymbolSCNX
Company nameScienture Holdings Inc
IPO dateFeb 18, 2020
CEODr. Narasimhan Mani
Number of employees14
Security typeOrdinary Share
Fiscal year-endFeb 18
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolSCNX
IPO dateFeb 18, 2020
CEODr. Narasimhan Mani
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
136.64K
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Shareholder Types
Shareholders
Proportion
Individual Investor
30.81%
Hedge Fund
0.61%
Investment Advisor
0.43%
Investment Advisor/Hedge Fund
0.23%
Other
67.92%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
28
4.45M
32.09%
+15.20K
2025Q1
32
4.45M
33.93%
+9.47K
2024Q4
36
4.62M
68.10%
+3.89M
2024Q3
36
1.01M
65.38%
+269.18K
2024Q2
37
1.00M
67.44%
+530.62K
2024Q1
34
476.38K
36.25%
+95.67K
2023Q4
35
386.59K
47.32%
+20.29K
2023Q3
38
376.26K
55.40%
-6.85K
2023Q2
38
402.57K
59.37%
+44.99K
2023Q1
42
365.94K
58.68%
-79.79K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hariharan (Shankar Ph.D.)
2.37M
18.07%
--
--
Jan 27, 2025
Mani (Narasimhan)
1.42M
10.79%
--
--
Jan 27, 2025
Ajjarapu (Surendra K)
210.10K
1.6%
--
--
Jan 27, 2025
Patel Prashant
176.69K
1.35%
--
--
Jan 27, 2025
Doshi (Mayur Mansukhlal)
66.45K
0.51%
--
--
Jan 27, 2025
Armistice Capital LLC
65.50K
0.5%
+36.65K
+127.04%
Dec 31, 2023
Susquehanna International Group, LLP
37.41K
0.29%
+37.41K
--
Mar 31, 2025
Fell (Donald G.)
35.16K
0.27%
--
--
Jan 27, 2025
Geode Capital Management, L.L.C.
32.16K
0.25%
+11.60K
+56.41%
Mar 31, 2025
Millennium Management LLC
14.68K
0.11%
-19.30K
-56.80%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Date
Type
Ratio
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
